Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 144
Selected: 0
NCT IDTitle
NCT07133269Care Coach-led Integrated Palliative Surgical Oncology and Rehabilitation Care Model for Advanced Cancer Patients
NCT07428356Histotripsy for Ablation of Liver Tumours in Asia
NCT02548039To Study The Influence Of Genomic Factors On Metabolism And Effects Of Clomiphene In Asian Normogonadotrophic Anovulatory Patients.
NCT00687648Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer
NCT04230330Nivolumab in Combination With GDP/ L-asparaginase in NK/ T-cell Lymphoma
NCT04303403Study of Trametinib and Ruxolitinib in Colorectal Cancer and Pancreatic Adenocarcinoma
NCT03188159Vinorelbine in Relapsed Platinum Resistant or Refractory C5 High Grade Serous, Endometrioid, or Undifferentiated Primary Peritoneum, Fallopian Tube or Ovarian Cancer
NCT01765686Comparing Harmonic Ultrasonic Scalpel to Small Jaw Bipolar Device in Thyroid Surgery
NCT02420067Screening for Endolymphatic Sac Tumours (ELSTs) in Von Hippel-Lindau (vHL) Patients
NCT03422432Prophylactic HIPEC for Colorectal Cancers at High Risk of Developing Peritoneal Metastases
NCT04986748Using QPOP to Predict Treatment for Sarcomas and Melanomas
NCT01341834Safety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven Tumors
NCT00565708Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers
NCT02143388Concurrent Cisplatin Chemoradiation With or Without Capecitabine as Adjuvant Chemotherapy in Local Advanced High Risk Nasopharyngeal Carcinoma: Randomized Control Clinical Trial
NCT01394315Diffuse Optical Tomography (DOT) for Monitoring Response to Neoadjuvant (Preoperative) Chemotherapy in Breast Cancer
NCT04242251Novel Palliative Care Model for Advanced Cancer Patients: A Randomized Controlled Trial Study
NCT05724264SingapOre Lung Cancer Screening Through Integrating CT With Other biomarkErs (SOLSTICE)
NCT01309607Study of Preoperative Weekly Paclitaxel and Carboplatin With Lapatinib (Tykerb®) in Patients With ErbB2-Positive Stage I-III Breast Cancer
NCT05516628Deep, Multi-omics Phenotyping to Predict Response, Resistance and Recurrence to Adjuvant Atezolizumab Plus Bevacizumab in Resected Hepatocellular Carcinoma
NCT05957068Breast Cancer Exercise Intervention Study
NCT03200730A Novel Family Dignity Intervention (FDI) for Asian Palliative Care
NCT06172595FET PET in Differentiating Tumour Progression From Pseudoprogression in High Grade Glioma
NCT04956068PIPAC for Peritoneal Metastases
NCT01570296A Trial of Gefitinib in Combination With BKM120 in Patients With Advanced Non-Small Cell Lung Cancer, With Enrichment for Patients Whose Tumours Harbour Molecular Alterations of PI3K Pathway and Known to Overexpress EGFR
NCT03430128Perioperative Immunonutrition for Patients Undergoing CRS and HIPEC
NCT04946968Phase-2 Dacomitinib Study on Patients With EGFR-Driven Advanced Solid Tumours With Low EGFR-AS1 IncRNA Expr or Other Novel Emerging Biomarkers
NCT05581550Somatostatin Receptor Imaging in NPC, EBV Related Cancers
NCT00957086Study of Post-Op Adjuvant Concurrent Chemo-RT With or Without Nimotuzumab for Head & Neck Cancer
NCT05581979PSMA-PET Imaging of Salivary Gland Tumours and Other Rare Cancers
NCT05198479Phase II 177Lu-DOTATATE Study in Metastatic NPC With a Safety Run-in
NCT04224480Longitudinal Immune-phenotyping of HCC Following MK-3475
NCT06194084Impacts of Durian Consumption on Human Microbiome and Metabolome in Healthy Staff Volunteers
NCT04087473Plasma Molecular Profiling in ALK Inhibitor Resistant NSCLC
NCT02931864Effects of an e-Home Based Symptom Management and Mindfulness Training Programme on QoL in Breast Cancer Survivors
NCT04664829The Role of Bexarotene in Inducing Susceptibility to Chemotherapy in Metastatic TNBC
NCT03212937Phase I Trial of Selinexor (KPT-330) and Ifosfamide, Carboplatin, Etoposide (ICE) in Peripheral T-cell Lymphoma
NCT03093831Phase II Study of Ibrutinib in Patients With Relapsed or Refractory Marginal Zone Lymphoma
NCT03100006Phase Ib/IIa Trial to Evaluate Oregovomab and Nivolumab in Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin
NCT05929885Metronomic Capecitabine, Oxaliplatin and UGT1A1 Genotype-directed Irinotecan in Metastatic Pancreatic Cancer Patients
NCT00997906Cisplatin and RT With or Without Gemcitabine, Carboplatin, and Paclitaxel in Treating Patients With Locally Advanced NPC
NCT06587295Intramuscular ACM-CpG Monotherapy in Patients With Advanced/Metastatic Solid Tumors With Prior Response to Immunotherapy Alone or in Combination With Chemotherapy
NCT00263484Higher Frequency Zoledronic Acid in the Treatment of Multiple Myeloma
NCT04118114Phase II Study of PRL3-ZUMAB in Advanced Solid Tumors
NCT02804776PRe-Operative Gefitinib in Resectable EGFR Mutation Positive Lung Cancer With Sector Sequencing for Biomarker Discovery
NCT04451603LiverMultiScan Analysis of MRI Scans in HCC
NCT06244953Timely Interventions to Enable and Reach Patients With Heart Failure, and Their Caregivers With Palliative Care
NCT04072107EPstein-barr Virus DNA Response to Systemic Therapy for Treatment Adaptation in High Risk NPC (EP-STAR)
NCT07013461International Collaborative Study on AJCC/UICC TNM-10 for Nasopharyngeal Cancer
NCT03670342Pilot Study of Somatostatin Receptor Imaging in Nasopharyngeal Cancer
NCT05517135tReatment Individualisation By EBV stratificatiON in Nasopharyngeal Carcinoma: an Umbrella Platform Study (RIBBON-Umbrella)